New Entrant Makes Moves in the Toxin Market
Share This Episode
In this month’s podcast David Moatazedi joins host Grant Stevens, MD to discuss the latest developments at Evolus, his new role as CEO and how doctors are involved with the company as they prepare for commercialization in 2019.
David shares insight into their plans, an in-depth review of Evolus, its new management team and its competitive advantages. He also answers several questions that are on the top of many of our minds.
Don’t miss out and listen today.